The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
Nokia Oyj
OMXH:NOKIA
|
FI |
|
N
|
Nov Inc
XMUN:NO8
|
US |
|
I
|
International Cement Group Ltd
SGX:KUO
|
SG |
|
B
|
Benefit Systems SA
WSE:BFT
|
PL |
|
Endesa SA
MAD:ELE
|
ES |
|
Teekay Corp
NYSE:TK
|
BM |
|
P
|
Pasquarelli Auto SpA
MIL:PSQ
|
IT |
|
D
|
Dino Polska SA
WSE:DNP
|
PL |
|
Pininfarina SpA
MIL:PINF
|
IT |
|
Eurazeo SE
OTC:EUZOF
|
FR |
|
Farmers National Banc Corp
NASDAQ:FMNB
|
US |
|
O
|
Oportun Financial Corp
F:4L0
|
US |
|
Citra Marga Nusaphala Persada Tbk PT
IDX:CMNP
|
ID |
|
Premia Finance SpA Societa di Mediazione Creditizia
MIL:PFI
|
IT |
|
Bastogi SpA
MIL:B
|
IT |
|
S
|
Sixt SE
XHAN:SIX3
|
DE |
|
P
|
Puranium Energy Ltd
CNSX:UX
|
CA |
|
K
|
Kadant Inc
F:KDA
|
US |
|
N
|
NewEn AI Co Ltd
KOSDAQ:463020
|
KR |
|
Landstar System Inc
NASDAQ:LSTR
|
US |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
Aurora Cannabis Inc
F:21P
|
CA |
|
C
|
Cosmax NBT Inc
KOSDAQ:222040
|
KR |
ANI Pharmaceuticals Inc (ANIP)’s 12-month stock price forecast through November 2027 has a consensus target of $104.04, implying 45% upside. The forecast is based on price targets from 11 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
ANIP is 104.04 USD with a low forecast of 85.85 USD and a high forecast of 127.05 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 8%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 35%. The projected CAGR for the next 5 years is 12%.
The compound annual growth rate for Operating Income over the next 8 years is 20%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 56%.
The compound annual growth rate for Net Income over the next 8 years is 23%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more